𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia

✍ Scribed by Zhijian Qian; John M. Joslin; Thelma R. Tennant; Shalini C. Reshmi; David J. Young; Angela Stoddart; Richard A. Larson; Michelle M. Le Beau


Book ID
113518033
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
556 KB
Volume
184
Category
Article
ISSN
0009-2797

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Acute myeloid leukemia developing during
✍ Attaphol Pawarode; Sheila N.J. Sait; Alain Nganga; Lionel J. Coignet; Maurice Ba πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 171 KB

The BCR/ABL tyrosine kinase inhibitor imatinib mesylate produces a high rate of cytogenetic responses in patients with Philadelphia (Ph)-positive chronic myeloid leukemia (CML), but secondary clonal chromosome abnormalities may develop in Ph-negative cells, and acute myeloid leukemia (AML) has been